• Nadeem S. Sheikh
  • Azeem S. Sheikh
  • Aqleem A. Sheikh


Background: The objective of this study was to determine the knowledge, attitude and practices regarding Crimean-Congo Haemorrhagic Fever (CCHF) among healthcare workers at a tertiary care referral hospital in Balochistan. Methods: A cross-sectional survey was conducted in April - May 2000 among the doctors, nurses and laboratory technicians of Sandeman Provincial Teaching Hospital, Quetta, Balochistan. A questionnaire was formulated which included the demographic data of the respondents and their knowledge, attitude and practices towards CCHF. Results: A total of 235 healthcare personnel including 150(63.8%) doctors, 50(21.2%) nurses and 35(15%) laboratory technicians were interviewed during the survey. Seventy percent (164) of the subjects were males while 30% (71) were females. One fifty-five (66%) of the total respondents claimed to know what CCHF was. By designation 120 (80%) of doctors, 30 (60%) of nurses and 5 (14%) of laboratory technicians had a prior knowledge about CCHF. One twenty (80%) of the doctors knew the most common presentations of CCHF. All categories of the respondents had a poor knowledge regarding the burial procedure of dead patients. Conclusion: This study was an indicator of the poor level of knowledge of healthcare workers regarding the clinical presentations and the modes of spread of CCHF. It is the dire need of the time to educate the healthcare workers about the common preventive measures of this disease, which has resulted in the loss of several important lives in the past in this region.KEY WORDS: Viral Haemorrhagic Fever, Haemorrhagic Fever, Crimean Congo Haemorrhagic Fever.


CDC update. Management of patients with suspected Viral Haemorrhagic Fever. MMWR 1998; 37: 1-16.

Hoogstral H. The epidemiology of tick-borne Crimean – Congo Haemorrhagic Fever in Asia, Europe and Africa. J Med Entomol 1979;15: 307-17.

Burney MI. Nosocomial outbreak of Viral Haemorrhagic Fever caused by Crimean – Congo Haemorrhagic Fever. Virus in Pakistan, January 1976; Am J Trop Med Hyg 1980; 29: 941-47.

Fisher-Hoch SP. Crimean – Congo Haemorrhagic Fever treated with oral ribavirin. Lancet 1995; 336: 472-75.

Swanepoel R. Nairovirus infections. In: Exotic Viral Infections: Porterfield, JS (ed): London,Chapman and Hall, 1995; 285-93.

Swanepoel R. The clinical pathology of Crimean – Congo Haemorrhagic Fever. Rev Infect Dis 1989;11:794-800.

Fisher-Hoch SP. Risk of human infection with Crimean-Congo Haemorrhagic Fever in a South African rural community. Am J Trop Med Hyg 1992; 47: 337-45.

Leshchinskaya EV. Clinical picture of Crimean Haemorrhagic Fever (in Russia). Trudy Inst Polio Virus Entsef Akad Med Nauk SSSR 1965;7:226-36.

Altaf A. Outbreak of Crimean – Congo Haemorrhagic Fever in Quetta, Pakistan: Contact tracing and risk assessment. Trop Med Int Health 1998;3:878-82.

Bosan AH. Crimean-Congo Haemorrhagic Fever outbreak in Karachi. Pak J Med Res 2002;41(1):36-8.

Begum F, Wisseman CL, Casals J. Tick borne viruses of Pakistan. Viruses similar to or identical with Crimean Haemorrhagic Fever, Wad Medani and Pak Argas 461 isolated from ticks of Changa Manga forest, Lahore district and Hunza, Gilgit Agency, Pakistan. Am J Epidem 1970; 92: 197-202.

CDC Update. Management of patients with suspected Viral Haemorrhagic Fever – United States. MMWR 1995; 44: 475-79.

Baron RC, McCormick JB, Zubair OA. Ebola virus disease in Southern Sudan: hospital dissemination and intrafamilial spread. Bull. WHO, 1983; 61: 997-1003.

Qureshi JA. An epidemic of Dengue Fever in Karachi; associated clinical manifestations. J Pak Med Assoc 1997; 47: 178-81.

Watts DM, Ussery MA, Nash D, Peters CJ. Inhibition of Crimean-Congo Haemorrhagic Fever Viral infectivity yields in - vitro by ribavirin. Am J Trop Med Hyg 1989;41:591-95.

Tignor GH, Hanham CA. Ribavirin efficacy in an in – vivo model of Crimean – Congo Haemorrhagic Fever (CCHF) virus infection. Antiviral Res 1993; 22: 309-25.

Huggins JW. Prospects for treatment of Viral Haemorrhagic Fevers with ribavirin, a broad-spectrum antiviral drug. Rev Infect Dis 1989; ii: 750-61.


Most read articles by the same author(s)